Low bone mass in Noonan syndrome children correlates with decreased muscle mass and low IGF-1 levels
Copyright © 2021 Elsevier Inc. All rights reserved..
Although musculoskeletal abnormalities have long been described in patients with Noonan syndrome (NS), only a few studies have investigated the bone status of these patients. The aim of this retrospective observational study was to describe the bone health of children with NS. Thirty-five patients with a genetically confirmed diagnosis of NS were enrolled. We analyzed the axial skeleton (lumbar spine) using dual energy X-ray absorptiometry and the appendicular skeleton (hand) with the BoneXpert system. Bone metabolism markers, including mineral homeostasis parameters, serum 25-hydroxy vitamin D (25-OHD) levels and markers of bone formation and resorption were also reported. Compared to the general population, axial and appendicular bone mass was significantly decreased in children with NS (p < 0.0001). Serum 25-OHD levels were low in about half of the patients and were negatively correlated with age (r = -0.52; p < 0.0001). Patients with NS exhibited reduced bone formation marker levels and increased bone resorption marker levels (p < 0.0001). No gender difference or genotype-phenotype correlations were found for the different bone parameters. Muscle mass and, to a lesser extent, serum insulin-like growth factor 1 (IGF-1) levels were independent predictors of whole-body bone mineral content (p < 0.0001 for both parameters; adjusted R2 = 0.97). In conclusion, bone mass is reduced in children with NS and correlates with decreased muscle mass and low serum IGF-1 levels. These data justify addressing all potential threats to bone health including sufficient calcium and vitamin D intake, regular physical exercise, and hormone replacement therapy.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2021 |
|---|---|
| Erschienen: |
2021 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:153 |
|---|---|
| Enthalten in: |
Bone - 153(2021) vom: 01. Dez., Seite 116170 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Delagrange, Marine [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
67763-96-6 |
|---|
| Anmerkungen: |
Date Completed 25.10.2021 Date Revised 31.05.2022 published: Print-Electronic Citation Status MEDLINE |
|---|
| doi: |
10.1016/j.bone.2021.116170 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM330346997 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM330346997 | ||
| 003 | DE-627 | ||
| 005 | 20231225211107.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231225s2021 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1016/j.bone.2021.116170 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1101.xml |
| 035 | |a (DE-627)NLM330346997 | ||
| 035 | |a (NLM)34492361 | ||
| 035 | |a (PII)S8756-3282(21)00336-7 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Delagrange, Marine |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Low bone mass in Noonan syndrome children correlates with decreased muscle mass and low IGF-1 levels |
| 264 | 1 | |c 2021 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 25.10.2021 | ||
| 500 | |a Date Revised 31.05.2022 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a Copyright © 2021 Elsevier Inc. All rights reserved. | ||
| 520 | |a Although musculoskeletal abnormalities have long been described in patients with Noonan syndrome (NS), only a few studies have investigated the bone status of these patients. The aim of this retrospective observational study was to describe the bone health of children with NS. Thirty-five patients with a genetically confirmed diagnosis of NS were enrolled. We analyzed the axial skeleton (lumbar spine) using dual energy X-ray absorptiometry and the appendicular skeleton (hand) with the BoneXpert system. Bone metabolism markers, including mineral homeostasis parameters, serum 25-hydroxy vitamin D (25-OHD) levels and markers of bone formation and resorption were also reported. Compared to the general population, axial and appendicular bone mass was significantly decreased in children with NS (p < 0.0001). Serum 25-OHD levels were low in about half of the patients and were negatively correlated with age (r = -0.52; p < 0.0001). Patients with NS exhibited reduced bone formation marker levels and increased bone resorption marker levels (p < 0.0001). No gender difference or genotype-phenotype correlations were found for the different bone parameters. Muscle mass and, to a lesser extent, serum insulin-like growth factor 1 (IGF-1) levels were independent predictors of whole-body bone mineral content (p < 0.0001 for both parameters; adjusted R2 = 0.97). In conclusion, bone mass is reduced in children with NS and correlates with decreased muscle mass and low serum IGF-1 levels. These data justify addressing all potential threats to bone health including sufficient calcium and vitamin D intake, regular physical exercise, and hormone replacement therapy | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Research Support, Non-U.S. Gov't | |
| 650 | 4 | |a Bone mass | |
| 650 | 4 | |a Insulin-like growth factor 1 | |
| 650 | 4 | |a Muscle mass | |
| 650 | 4 | |a Noonan syndrome | |
| 650 | 4 | |a RAS/ERK signaling pathway | |
| 650 | 4 | |a RASopathies | |
| 650 | 7 | |a Insulin-Like Growth Factor I |2 NLM | |
| 650 | 7 | |a 67763-96-6 |2 NLM | |
| 700 | 1 | |a Rousseau, Vanessa |e verfasserin |4 aut | |
| 700 | 1 | |a Cessans, Catie |e verfasserin |4 aut | |
| 700 | 1 | |a Pienkowski, Catherine |e verfasserin |4 aut | |
| 700 | 1 | |a Oliver, Isabelle |e verfasserin |4 aut | |
| 700 | 1 | |a Jouret, Béatrice |e verfasserin |4 aut | |
| 700 | 1 | |a Cartault, Audrey |e verfasserin |4 aut | |
| 700 | 1 | |a Diene, Gwenaelle |e verfasserin |4 aut | |
| 700 | 1 | |a Tauber, Maithé |e verfasserin |4 aut | |
| 700 | 1 | |a Salles, Jean-Pierre |e verfasserin |4 aut | |
| 700 | 1 | |a Yart, Armelle |e verfasserin |4 aut | |
| 700 | 1 | |a Edouard, Thomas |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Bone |d 1992 |g 153(2021) vom: 01. Dez., Seite 116170 |w (DE-627)NLM01297238X |x 1873-2763 |7 nnns |
| 773 | 1 | 8 | |g volume:153 |g year:2021 |g day:01 |g month:12 |g pages:116170 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1016/j.bone.2021.116170 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 153 |j 2021 |b 01 |c 12 |h 116170 | ||